known for some time to occur in diseases associated with neoplastic or inflammatory processes. These substances have been variously termed polypeptides (1) (2) (3) (4) , proteoses (5), mucoid-like material (6) , seromucoid (7) (8) (9) (10) , and mucoprotein (11) (12) (13) (14) (15) . It was only recently that the occurrence of a pathologic depression of the seromucoid (SM) level* was discovered, observed principally in hepatic disease (16) (17) (18) (19) . Thus, the incidence of a low SM level among 180 patients with either viral hepatitis or portal cirrhosis was about 80 per cent and compared favorably in diagnostic efficiency with the usual flocculation and other hepatic tests. On the other hand, only 2 per cent of 125 cases of obstructive jaundice showed a subnormal level, while 50 per cent had an increase (18, 19) . Since the test, in addition to its reputed diagnostic utility in such conditions as rheumatic fever and renal disease (20, 21) , promised to be a useful means of distinguishing between "medical" and "surgical" jaundice (22) -an ever-present clinical problem-it was being considered by the authors for adoption in the routine hospital laboratory. As a necessary preliminary step, an attempt was made to reappraise the clinical significance of the test. The results of this study, which, in part, were in discord with the cited published findings, are reported here. (26) . Serum (usually 4 ml., never less than 2 ml.) was treated with twice the volume of 0.6M perchloric acid. After exactly 10 minutes of standing and subsequent filtering through Whatman 5 paper, filtrate and 5% phosphotungstic acid (in 2N HC1) were, in a volume ratio of 3: 1, placed in a 15 ml. centrifuge tube, gently mixed, and spun 15 minutes later at about 500 G. for 10 minutes.
MATERIAL AND METHODS

Patients
The seromucoid precipitate was washed once with the phosphotungstic acid solution and, after thorough drainage, dissolved in 3 ml. of 0.2N NaOH and 0.6 ml. of hiuret reagent. After one hour's standing in a dark cabinet, the samples were read in a Beckman
Model DU spectrophotometer at 540 mi. Calculation of the SM content was made by reference to a standard curve obtained by means of solutions of 50 to 200 mg. of casein per 100 ml. of 0.2N NaOH, treated with biuret. as indicated above.
RESULTS
Aiialvsis of SM values determined among the normal controls revealed no striking difference between the fasting and nonfasting groups, if one discounts the low upper extreme in the nonfasting female group because of the small number of observations (Table 1) . In individual cases, however, food intake did seem to influence the SM level, contrary to Green- In view of these limitations and the relatively small number of "nor-mal" subjects studied, the 65 per cent confidence limits (27) to thymol turbidity in uncomplicated hepatic disease. Less than one third of the cases showed, upon initial testing, a normal thymol turbidity (below S units) while more than one half had a normal or elevated (negative) seromucoid. In 6 instances, seromucoid was positive and thymol negative; in 9, both tests failed to indicate hepatic disease.
test ( to severity of viral hepatitis as denoted by serum billrubin. In all but 9 patients, the serum bilirubin was above 4 mg./100 ml. on initial examination. Most of the corresponding seromucoid values were either normal or low. x test (27) failed to suggest correlation between seromucoid and bilirubin. surgical operations, pneumonia, pyelonephritis, mastitis, pregnancy), to which the failure of SM depression could be ascribed. Even if these cases were eliminated, reducing the group to 35 cases, there was stifi about one half of these which yielded a normal or, in 2 instances, elevated SM without evidence of an extrahepatic "SM-raising" process. While some of these patients had suffered a mild attack or were already in the recovery stage, as indicated by the low serum bilirubin level (Fig. 3) , about one half of them showed considerable jaundice, malaise, and associated laboratory evidence of hepatic damage (Fig. 4) at the time of the SM test.
Absence of SM depression appeared to characterize a group of 6 patients presenting an acute hepatitis syndrome secondary to certain systemic disorders: infectious mononucleosis, leptospirosis (two), amoebiasis, acute bacterial endocarditis, and intoxication with bootleg whiskey.
Since complications likely to augment the SM level (chronic pyelonephritis, pneumonia, subphrenic abscess, lymphopathia venereum, urticaria, and delirium tremens) occurred in the majority of the 41 patients with alcoholic cirrhosis, it was not surprising that only 6 (15 per cent) showed a subnormal SM level. In 2 instances, a high initial SM was associated with prolonged fever and leukocytosis, attributed to enterogenous bacteremia; subsidence of these signs of inflammation weeks later was accompanied by SM depression. Of the 14 patients in this group who showed no evidence of complications, there were stifi 2 with an increased and only 6 (43 per cent) with a low SM. The latter finding was also encountered in the 3 cases of postnecrotic cirrhosis, in 1 of the 2 cases of cardiac cirrhosis, and in 1 of 3 cases of sarcoidosis. SM was elevated in a patient with hemochromatosis but apparently not affected by fatty infiltration of the liver.
Thus, the incidence of significantly reduced SM levels in the group of turbidity tests were positive approximately twice as often in viral hepatitis and nearly three times as often in cirrhosis (Table 3) . Even after exclusion of cases with extrahepatic complications, the incidence of diagnostic SM levels was still below 50 per cent. These findings are strikingly different from Greenspan's, who reported the incidence of a subnormal SM in hepatitis and cirrhosis as being 88 per cent and 70 per cent, respectively, while the cephalin flocculation and thymol turbidity tests gave less frequent positive results: 48 and 68 per cent, respectively, in hepatitis, and 41 and 39 per cent in cirrhosis.
With regard to the serum alkaline phosphatase, experiences of the authors correspond more closely with those of Greenspan's in that this test yielded a positive result less often than the SM test (results of the two series are not directly comparable because of the differences in critical enzyme levels used).
On the other hand, in 55 cases of biliary obstruction (Table 2 ; Fig. 3 ) not a single instance of a subnormal SM was encountered while the two routine flocculation tests gave 20 per cent of "false" positive reactions (Table 3) ; the alkaline phosphatase failed in 27 to 43 per cent of the cases to show a marked elevation. In nearly three times as many cases of obstructive jaundice, Greenspan and his associates found the incidence of a subnormal SM level to be less than 3 per cent (19) . Hence, a subnormal SM level in the presence of jaundice is almost specific for a primary parenchymal disease, a statement that cannot be made for any of the commonly used hepatic tests. The SM test may therefore be most valuable in problems involving the differentiation of "medical" from "surgical" jaundice when the usual clinical and laboratory technics give equivocal results: a subnormal level weighs heavily in favor of "medical" jaundice. The utility of the test was clearly enhanced by the use of follow-up determinations (17, 21) ; not infrequently, when the first test gave a normal or borderline SM value, examination a few days later revealed a distinct tendency of the SM level to rise or fall, (15) . Although these investigators disregarded the existing sex difference in the normal SM concentration (Table 1 ) (17), their conclusions conform to Greenspan's (19) and the authors' experiences. Recognition of abnormal (high or low) levels is obviously dependent upon the definition of the "normal range," which in the present study was quite arbitrarily established as the 65 per cent confidence limits of all normal values encountered. Had the 95 per cent limits been used (Table 1) , which would be more acceptable from a statistical point of view, the incidence of subnormal values would have been far lower than above recorded, whereas the number of high levels would have decreased but slightly (Figs. 3-5 ). The absence of any apparent false-positive results furnished by the values herein designated as subnormal lends some justification to the choice of the normal range as presented; additional support stems from the close similarity to the normal extremes employed by Greenspan and coworkers (17) . However, these, as well as other problems of a more technical nature mentioned initially, throw a suspicious light on the reliability of the analytic method and on the biologic significance of the results. Seromucoid obviously does not represent a single substance but rather a serum fraction whose separation from the other serum proteins by means of perchioric acid or other reagents (sulfosalicylic acid, trichioracetic acid [5, 11] ) is quite arbitrary. This fact is evident from the marked changes in SM values that can be produced by relatively small alterations in the concentration of either acid or serum proteins or in the proportion of acid to serum (11, 26, 28) . Increases in serum globulin such as are observed in sarcoidosis or multiple myeloma apparently tend to reduce the SM level (18) , presumably through physicochemical action.
Electrophoretic analysis of perchioric-acid-serum filtrates revealed the presence of at least 3 peaks (MP-1, MP-2, and MP-3) (11, 29) . Chemically, carbohydrate (galactose-mannose), hexosamine and protein (measured as tyrosine) constituted, aside from lipids, the chief components, in a ratio of 15.1:11.9:4.2 (by weight, on a moisture-free basis). Since the carbohydrate: protein (tyrosine) ratio was apparently maintained when the SM (tyrosine) level was markedly elevated in patients with cancer or pneumonia, it was concluded that the material responsible for the increase was chemically similar (but not necessarily identical!) to that isolated from normal serum (12) . However, subnormal SM values (expressed as casein) encountered in liver disease were associated with increased carbohydrate:protein ratios (17) . With the use of ammonium sulfate fractionation, an electrophoretically and ultracentrifugally homogeneous plasma mucoid (M-1, corresponding to MP-1) was prepared by Winzler and his associates (30, 31) . This had a molecular weight of 44,100, the mobility of ai-globulin, and an isoelectric point of pH 1.8 at a buffer pH of 8.6; it contained approximately 26 per cent of carbohydrate (including hexosamine) and 10 per cent of "sialic acid" (32) . The substance was finally isolated in crystallized form by Schmid from Cohn's fraction VI (33) . Variations of this "acid glycoprotein" due to disease have, in the absence of a practical clinical method, not been reported.
It is thus obvious that seromucoid, as determined in perchloric acid filtrates, does not represent a chemical or biologic entity. There is much question as to whether increases or decreases of certain of its constituents -protein, hexosamine, hexose polysaccharide, or others-necessarily reflect equivalent fluctuations of the whole complex. Consequently, any speculation about the mechanism responsible for changes in SM concentration found in various disease states are bound to be superficial and fraught with error.
It has been suggested that serum glycoproteins originate from the depolymerization of ground substance of connective tissue (34, 35) . This process, normally under enzymatic and hormonal control, may be augmented by certain alterations in tissue metabolism, particularly those associated with destruction or proliferation, causing an excess of soluble, lower-molecular substances to diffuse into the circulation (34) (35) (36) (37) (38) and be excreted in the urine (39) . These substances are only in part represented by seromucoid which is devoid of hexuronic acids (10, 11, 30, 32, 33) , the regular constituents of tissue glycoprotein (40) . Hexuronic acids (41, 42) , as well as polysaccharides other than those contained in seromucoid, are normally present in serum (37) and may be pathologically increased. The decrease in the concentration of seromucoid (but not of those carbohydrate derivatives) occurring in liver disease suggests that the liver may act either as another source of SM or as an organ capable of removing it from the blood stream. The former possibility, implying inadequate synthesis by the diseased liver (18) , is suggested by Werner's observations on the serum hexosamine response of rabbits subjected to blood loss; the usual increase failed to occur when liver damage was produced by means of phosphorus or chlorobenzene (43) . On the other hand, total protein-bound hexose polysaccharides have been found in normal or increased serum concentrations in viral hepatitis (17) . The role of the liver as a source of SM is also suggested by the finding of reduced ai-globulin in viral hepatitis (44, 45) and by the observation, based on C' isotope studies, that most of the major serum protein fractions stem from the liver, except for v-globulin and minute amounts of -and a-globulins (46, 47) .
As a working hypothesis, connective tissue and the hepatic parenchyma may be regarded as two independent sources of seromucoid, each source having a different type of response to physiologic stimulation or injury: the former chiefly in the form of an increase, the latter by way of a decrease. The SM level, as analyzed at any given time, constitutes the sum of these responses. Thus, only marked preponderance of the response of one source over that of the other will result in a distinctly abnormal and diagnostically useful level. The combination of two severe responses, i.e., pneumonia and viral hepatitis, is liable to yield a normal level.
This theory leaves open the question of endocrine factors influencing the SM level (48) (49) (50) (51) The empirical data point to the lower limit of the normal seromucoid range as providing a useful dividing line between obstructive and parenchymal jaundice: the finding of a subnormal level is strongly indicative of the latter. Normal or elevated levels may only occasionally be expected to make a decisive diagnostic contribution.
A more definitive evaluation of the clinical utility of this type of test must await improvements in analytic standardization, based on a more detailed knowledge of the chemical and physiologic identity of the compound than is available at present.
